1.800.KIDS DOC | 1.800.543.7362

David O. Walterhouse, MD

David O. Walterhouse, MD

Section Head, Oncology; Attending physician, Hematology/Oncology; Richard A. Perritt, MD Professorship in Cancer and Blood Disorders

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Interim Director, Cancer Biology & Epigenomics Program, Stanley Manne Children's Research Institute

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Differentiation and development, molecular oncogenesis, sarcoma treatment, solid tumor therapy

Specialties, Programs & Conditions

Specialties:

Hematology & Oncology

Education & Training

Education: University of Michigan, 1983

Postgraduate Training: Children's Hospital of Philadelphia, 1989, 1986, 1984

Board Certifications: Pediatric Hematology-Oncology, General Pediatrics

Research

Research Interests: Cancer biology; developmental biology; oncology; pediatrics; signal transduction

Publications

Most recent publications

Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group Pediatr Blood Cancer63 (4): 634-9
Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma Mol Cancer Res11 (6): 604-15
What is new in rhabdomyosarcoma management in children? Paediatr Drugs14 (6): 389-400
Three dimensional visualization and fractal analysis of mosaic patches in rat chimeras: cell assortment in liver, adrenal cortex and cornea PLoS One7 (2): e31609
Local Control With Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group D9602 Study Int J Radiat Oncol Biol Phys83 (2): 720-6
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group Pediatr Blood Cancer64 (9):
Sonic hedgehog regulation of Foxf2 promotes cranial neural crest mesenchyme proliferation and is disrupted in cleft lip morphogenesis Development144 (11): 2082-2091
Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: A report from the Children's Oncology Group Pediatr Blood Cancer61 (6): 970-6
Sonic hedgehog-responsive genes in the fetal prostate J Biol Chem284 (9): 5620-9

Call 1.800.543.7362 for Insurance information. 1.800.543.7362

News

1 Results

Fertility Preservation: Planning for Life After Cancer

See all News & Stories >